MCM
ACH

Manchester Capital Management’s Accendra Health ACH Stock Holding History

Manchester Capital Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$338 – 1191
2024
Q2 		$338 Hold
25
– – ﹤0.01% 1084
2024
Q1 		$693 Hold
25
– – ﹤0.01% 915
2023
Q4 		$482 Hold
25
– – ﹤0.01% 920
2023
Q3 		$404 Hold
25
– – ﹤0.01% 917
2023
Q2 		$476 Buy
+25
New +$446 ﹤0.01% 884
2023
Q1 		– Sell
-68
Closed -$1.33K – 1106
2022
Q4 		$1.33K Buy
68
+37
+119% +$722 ﹤0.01% 768
2022
Q3 		$1K Sell
31
-2
-6% -$62 ﹤0.01% 808
2022
Q2 		$1K Sell
33
-36
-52% -$1.3K ﹤0.01% 860
2022
Q1 		$3K Hold
69
– – ﹤0.01% 749
2021
Q4 		$3K Buy
69
+3
+5% +$118 ﹤0.01% 775
2021
Q3 		$2K Buy
+66
New +$2.6K ﹤0.01% 876

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manchester Capital Management's ACH Position: Q3 2024 in Review

Manchester Capital Management sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 25 shares — an estimated $338 sold.

Manchester Capital Management first reported a position in ACH in Q3 2021 and held it in 11 quarters. The position peaked at $3K in Q1 2022. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Manchester Capital Management reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Manchester Capital Management sold 25 Accendra Health shares in Q3 2024, an estimated $338.
  • Manchester Capital Management first reported a position in Accendra Health in Q3 2021 and held it in 11 quarters.
  • Manchester Capital Management's Accendra Health position peaked at $3K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Manchester Capital Management's 13F filing for Q3 2024, filed 5 Nov 2024.